Read + Share
Amedeo Smart
Independent Medical Education
Halle O, Graeber SY, Kontsendorn J, Kessemeier C, et al. Reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor correlates with lung function improvement in cystic fibrosis. Eur Respir J 2025;66:2500150.PMID: 40967763
Email
LinkedIn
Privacy Policy